EUVIMEDEUVIMED entdecken
Leitlinie

Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society

Honorio T Benzon iD, David Anthony Provenzano iD, Ameet Nagpal iD, Dmitri Souza, Maxim S Eckmann, Ariana M Nelson iD, Maged Mina, Alaa Abd-Elsayed, Dalia Elmofty, Andrea L Chadwick iD, Tina L Doshi iD, Carlos A Pino iD und 18 weitere

Regional Anesthesia & Pain Medicine · 2026-07 · 51 (7) · 746-773

DOI: 10.1136/rapm-2024-105656 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Regional Anesthesia & Pain Medicine, online erschienen am 26.02.2025. Verfasst von Honorio T Benzon und 29 weiteren Autor:innen. Beteiligte Einrichtung: Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Honorio.Benzon@nm.org. Hauptthemen laut MEDLINE: Adrenal Cortex Hormones, Joints, Societies, Medical. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 289 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intra-articular corticosteroid (IACS) injection and peri-articular corticosteroid injection are commonly used to treat musculoskeletal conditions. Results vary by musculoskeletal region, but most studies report short-term benefit with mixed results on long-term relief. Publications showed adverse events from single corticosteroid injections. Recommended effective doses were lower than those currently used by clinicians.

Methods

Development of the practice guideline for joint injections was approved by the Board of Directors of the American Society of Regional Anesthesia and Pain Medicine and the participating societies. A Corticosteroid Safety Work Group coordinated the development of three guidelines: peripheral nerve blocks and trigger points; joints; and neuraxial, facet, and sacroiliac joint injections. The topics included safety of the technique in relation to landmark-guided, ultrasound-guided, or radiology-aided injections; effect of the addition of the corticosteroid on the efficacy of the injectate; and adverse events related to the injection. Experts on the topics were assigned to extensively review the literature and initially develop consensus statements and recommendations. A modified version of the US Preventive Services Task Force grading of evidence and strength of recommendation was followed. A modified Delphi process was adhered to in arriving at a consensus.

Results

This guideline focuses on the safety and efficacy of corticosteroid joint injections for managing joint chronic pain in adults. The joints that were addressed included the shoulder, elbow, hand, wrist, hip, knee, and small joints of the hands and feet. All the statements and recommendations were approved by all participants and the Board of Directors of the participating societies after four rounds of discussion. There is little evidence to guide the selection of one corticosteroid over another. Ultrasound guidance increases the accuracy of injections and reduces procedural pain. A dose of 20 mg triamcinolone is as effective as 40 mg for both shoulder IACS and subacromial subdeltoid bursa corticosteroid injections. The commonly used dose for hip IACS is 40 mg triamcinolone or methylprednisolone. Triamcinolone 40 mg is as effective as 80 mg for knee IACS. Overall, IACS injections result in short-term pain relief from a few weeks to a few months. The adverse events include an increase in blood glucose, adrenal suppression, detrimental effect on cartilage lining the joint, reduction of bone mineral density, and postoperative joint infection.

Conclusions

In this practice guideline, we provided specific recommendations on the role of corticosteroids in joint, bursa, and peritendon injections for musculoskeletal pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex HormonesJointsSocieties, MedicalHumansInjections, Intra-ArticularUnited States

Stichwörter der Autor:innen

chronic painoutcomespain management

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Honorio.Benzon@nm.org.
  • Pain Diagnostics and Interventional Care, Sewickley, Pennsylvania, USA.
  • PM&R, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Pain Medicine, Summa Western Reserve Hospital, Cuyahoga Falls, Ohio, USA.
  • Anesthesiology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
  • Department of Anesthesiology and Perioperative Medicine, University of California, Irvine, Irvine, California, USA.

ORCID-Profile: Honorio T Benzon, David Anthony Provenzano, Ameet Nagpal, Ariana M Nelson, Andrea L Chadwick, Tina L Doshi, Carlos A Pino, Hariharan Shankar, Steven P Cohen, Samer Narouze, Harsha Shanthanna, Christine Hunt

Zitieren

APA

Benzon, H. T., Provenzano, D. A., Nagpal, A., Souza, D., Eckmann, M. S., Nelson, A. M., Mina, M., Abd-Elsayed, A., Elmofty, D., Chadwick, A. L., Doshi, T. L., Pino, C. A., Rana, M., Shah, S., Shankar, H., Stout, A., Smith, E., Abdi, S., Cohen, S. P., …, & FitzGerald, J. D. (2026). Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society. Regional Anesthesia & Pain Medicine, 51(7), 746-773. https://doi.org/10.1136/rapm-2024-105656

Vancouver

Benzon HT, Provenzano DA, Nagpal A, Souza D, Eckmann MS, Nelson AM, et al. Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society. Regional Anesthesia & Pain Medicine. 2026;51(7):746-773. doi:10.1136/rapm-2024-105656

BibTeX
@article{Benzon2026,
  author = {Benzon, Honorio T and Provenzano, David Anthony and Nagpal, Ameet and Souza, Dmitri and Eckmann, Maxim S and Nelson, Ariana M and Mina, Maged and Abd-Elsayed, Alaa and Elmofty, Dalia and Chadwick, Andrea L and Doshi, Tina L and Pino, Carlos A and Rana, Maunak and Shah, Shalini and Shankar, Hariharan and Stout, Alison and Smith, Elizabeth and Abdi, Salahadin and Cohen, Steven P and Hirsch, Joshua A and Schneider, Byron J and Manchikanti, Laxmaiah and Maus, Timothy P and Narouze, Samer and Shanthanna, Harsha and Wasan, Ajay D and Hoang, Thanh D and Rivera, Jessica and Hunt, Christine and FitzGerald, John D},
  title = {Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society},
  journal = {Regional Anesthesia & Pain Medicine},
  year = {2026},
  volume = {51},
  number = {7},
  pages = {746--773},
  doi = {10.1136/rapm-2024-105656}
}
Kostenlos starten →